SHEPPARD
Kristen

• 1. Education
• 2. Career

Kristen Sheppard is Senior Vice President, Investor Relations and Corporate Communications at Dicerna Pharmaceuticals.

Education

Ms. Sheppard holds a Juris Doctor from Suffolk University Law School and a Bachelor of Arts in political science from the University of New Hampshire. She is a member of the New Hampshire Bar Association.

Career

Kristen Sheppard joined Dicerna in September 2021 as Senior Vice President, Investor Relations and Corporate Communications. Ms. Sheppard has more than 20 years of experience in building and leading successful investor relations, corporate communications and public affairs functions across the biotechnology, medical device and technology sectors.

Ms. Sheppard joined Dicerna from Akebia Therapeutics, Inc. where she served as Senior Vice President, Investor Relations and Corporate Communications. Prior to Akebia, Ms. Sheppard was Vice President, Investor Relations and Counsel at NxStage Medical, Inc. from 2008 through its acquisition by Fresenius Medical Care in 2019, and also served most recently as the company’s Associate General Counsel. Prior to NxStage, Ms. Sheppard held senior leadership roles in investor relations for publicly traded and pre-IPO companies within the technology sector, and also served as senior government affairs and public policy counsel to various healthcare entities.